Follicular lymphoma (FL) is considered an indolent but incurable disease. It remains to be
clarified whether the outcome has changed after the recent introduction of novel treatment …

Background: Recent data from retrospective and prospective studies indicate an
improvement in the overall survival (OS) of follicular lymphoma (FL) patients (pt). We sought …

Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a
chronic, relapsing, indolent condition with long overall survival (OS). Most people affected …

Background The purpose of this study was to identify prognostic parameters for patients with
follicular lymphoma (FL) in first progression/relapse. These would be useful for selection of …

Background Follicular lymphoma is the second most common non-Hodgkin lymphoma in the
United States and Europe. However, most of the prospective randomized studies have very …

Background Follicular lymphomas (FLs) are a heterogeneous group of lymphomas. No
standard of care exists, and the management of these patients is highly individualized …

Purpose Despite several new treatment options, single-and multi-institution analyses have
not clarified whether survival patterns in follicular lymphoma (FL) patients have changed in …

Although the introduction of immunotherapy has improved outcomes for follicular lymphoma
(FL) patients, histological transformation (HT) and early relapse still confer a poor prognosis …

We assessed stage-specific trends in primary therapy and relative survival among adult
follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N …

Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …